لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Romano ER, Sleeman K, Hall-Eidson P, Zeh C, Bhairavabhotla R, Zhang G, Adhikari A, Alemnji G, Cardo YR, Pinheiro A, Pocongo B, Eno LT, Shang JD, Ndongmo CB, Rosario H, Moreno O, De León LAC, Fonjungo P, Kabwe C, Ahuke-Mundeke S, Gama D, Dlamini S, Maphalala G, Abreha T, Purfield A, Gebrehiwot YT, Desalegn DM, Basiye F, Mwangi J, Bowen N, Mengistu Y, Lecher S, Kampira E, Kaba M, Bitilinyu-Bangoh J, Masamha G, Viegas SO, Beard RS, van Rooyen G, Shiningavamwe AN, I J M, Iriemenam NC, Mba N, Okoi C, Katoro J, Kenyi DL, Bior BK, Mwangi C, Nabadda S, Kaleebu P, Yingst SL, Chikwanda P, Veri L, Simbi R, Alexander H

المصدر: Emerging infectious diseases [Emerg Infect Dis] 2022 Dec; Vol. 28 (13), pp. S59-S68.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC) Country of Publication: United States NLM ID: 9508155 Publication Model: Print Cited Medium: Internet ISSN: 1080-6059 (Electronic) Linking ISSN: 10806040 NLM ISO Abbreviation: Emerg Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/diagnosis , HIV Infections*, Humans ; COVID-19 Testing ; Pathology, Molecular ; Pandemics ; SARS-CoV-2

المؤلفون: Voetsch AC; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, GA., Duong YT; ICAP at Columbia University, New York, NY., Stupp P; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, GA., Saito S; ICAP at Columbia University, New York, NY., McCracken S; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, GA., Dobbs T; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, GA., Winterhalter FS; ICAP at Columbia University, New York, NY., Williams DB; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, GA., Mengistu A; Ministry of Health and Social Services, Windhoek, Namibia., Mugurungi O; Ministry of Health and Child Care, Harare, Zimbabwe., Chikwanda P; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, GA., Musuka G; ICAP at Columbia University, New York, NY., Ndongmo CB; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, GA., Dlamini S; National Reference Laboratory, Ministry of Health, Mbabane, Eswatini., Nuwagaba-Biribonwoha H; ICAP at Columbia University, New York, NY., Pasipamire M; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, GA., Tegbaru B; ICAP at Columbia University, New York, NY., Eshetu F; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, GA., Biraro S; ICAP at Columbia University, New York, NY., Ward J; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, GA., Aibo D; ICAP at Columbia University, New York, NY., Kabala A; ICAP at Columbia University, New York, NY., Mgomella GS; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, GA., Malewo O; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, GA., Mushi J; National AIDS Control Programme, Dodoma, Tanzania., Payne D; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, GA., Mengistu Y; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, GA., Asiimwe F; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, GA., Shang JD; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, GA., Dokubo EK; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, GA., Eno LT; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, GA., Zoung-Kanyi Bissek AC; Division of Health Operations Research, Ministry of Public Health, Yaoundé, Cameroon.; Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon., Kingwara L; Division of National AIDS and STI Control Program, Nairobi, Kenya ; and., Junghae M; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, GA., Kiiru JN; National Public Health Laboratory, Ministry of Health, Nairobi, Kenya., Mwesigwa RCN; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, GA., Balachandra S; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, GA., Lobognon R; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, GA., Kampira E; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, GA., Detorio M; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, GA., Yufenyuy EL; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, GA., Brown K; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, GA., Patel HK; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, GA., Parekh BS; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, GA.

المصدر: Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2021 Aug 01; Vol. 87 (Suppl 1), pp. S73-S80.

نوع المنشور: Journal Article; Research Support, U.S. Gov't, P.H.S.

بيانات الدورية: Publisher: Lippincott Williams & Wilkins, Inc Country of Publication: United States NLM ID: 100892005 Publication Model: Print Cited Medium: Internet ISSN: 1944-7884 (Electronic) Linking ISSN: 15254135 NLM ISO Abbreviation: J Acquir Immune Defic Syndr Subsets: MEDLINE

مواضيع طبية MeSH: Algorithms* , Epidemiological Monitoring* , HIV-1*, HIV Infections/*diagnosis, Adolescent ; Adult ; Anti-HIV Agents/therapeutic use ; Female ; HIV Infections/drug therapy ; Humans ; Incidence ; Male ; Middle Aged ; Young Adult

المؤلفون: Eno LT; US Centers for Disease Control and Prevention, Cameroon., Asong T; US Centers for Disease Control and Prevention, Cameroon., Ngale E; Global Health Systems Solution, Cameroon., Mangwa B; Global Health Systems Solution, Cameroon., Ndasi J; Global Health Systems Solution, Cameroon., Mouladje M; Buea Regional Hospital, Cameroon., Lekunze R; Cameroon Development Corporation, Central Clinic, Tiko., Mbome V; Regional Delegation for Health, Buea, Cameroon., Njukeng P; Global Health Systems Solution, Cameroon., Shang J; US Centers for Disease Control and Prevention, Cameroon.

المصدر: African journal of laboratory medicine [Afr J Lab Med] 2014 Nov 03; Vol. 3 (2), pp. 221. Date of Electronic Publication: 2014 Nov 03 (Print Publication: 2014).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: AOSIS OpenJournals Country of Publication: South Africa NLM ID: 101603205 Publication Model: eCollection Cited Medium: Print ISSN: 2225-2002 (Print) Linking ISSN: 22252002 NLM ISO Abbreviation: Afr J Lab Med Subsets: PubMed not MEDLINE

المؤلفون: Youngpairoj AS; Laboratory Branch, Division of HIV/AIDS Prevention, National Center for HIV, Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Alemnji GA, Eno LT, Lyonga EJ, Eloundou MA, Shanmugam V, Mpoudi EN, Folks TM, Kalish ML, Pieniazek D, Fonjungo PN

المصدر: AIDS research and human retroviruses [AIDS Res Hum Retroviruses] 2012 Jul; Vol. 28 (7), pp. 675-84. Date of Electronic Publication: 2011 Nov 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Mary Ann Liebert Country of Publication: United States NLM ID: 8709376 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1931-8405 (Electronic) Linking ISSN: 08892229 NLM ISO Abbreviation: AIDS Res Hum Retroviruses Subsets: MEDLINE

مواضيع طبية MeSH: Polymorphism, Genetic*, Drug Resistance, Viral/*genetics , HIV Protease/*genetics , HIV Protease Inhibitors/*pharmacology , HIV Seropositivity/*epidemiology , HIV Seropositivity/*genetics , HIV-1/*genetics , Reverse Transcriptase Inhibitors/*pharmacology, Adult ; Amino Acid Sequence ; Cameroon/epidemiology ; DNA, Viral/genetics ; Female ; Humans ; Male ; Molecular Sequence Data ; Mutation ; Phylogeny ; Prevalence